2025 H2 -tulosraportti
98 päivää sitten
‧38 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 3 332 | - | - | ||
| 17 034 | - | - | ||
| 3 127 | - | - | ||
| 2 834 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·45 min sittenI have been in the stock for some years, and I felt the same way as many of you. But every year I have looked, it has risen enormously. Get rid of stress and put the stock on the shelf for some months and come back 😊 I do that at least haha - not advice
·5 t sittenShould we all just smile and be content no matter what happens? When a company that seemingly has everything in order, is ready for production, and has a market that actually demands the product, falls nearly 11 % in four trading days – then I become skeptical. I still have faith, and I will continue to have it, but these are unhealthy fluctuations when only positive news is available. There is, of course, a lot of speculation and forces at play, but for 1/10 of the value of an entire company to disappear in under a week without a single piece of negative news, that's not good. So we'll see what happens going forward. I'm crossing my fingers that it turns around and stabilizes, but I must admit that I'm starting to wonder if the price target of 3,5 is realistic after all. Anyway – fingers crossed for a more stable journey ahead, with the arrow pointing upwards. Fingers crossed.
·3 t sittenWhat is happening now is completely normal. 3,5 I see as almost impossible. I guess the stock will accumulate well around 4 kr.
·5 t sittenThe stock is therefore experiencing significant volatility because investors are weighing DNB's fear of high short-term costs against Arctic's optimism regarding the accelerating global demand.
·7 t sittenIt looks like it is being systematically worked down. Smart move.
·5 t sitten · MuokattuAnyway, this level is not a big concern, it has been here several times, most recently in May. It was also significantly lower than this early in winter. An excellent buying opportunity for those who might want more shares. I bet we are a good way up when certificate of commission is signed, perhaps already before we take summer vacation. By the way, it's been a sad week in the entire stock world, a lot of red around the globe.
10 t sitten10 t sittenSNMMI 2026, one of the world's leading events for nuclear medicine - it's a wrap. A clear takeaway from this year's meeting in Los Angeles was the growing interest in lead-212 and the continued momentum behind targeted alpha therapies. It was a productive week for Thor Medical's CEO, Jasper C. Kurth, and Head of Communications & Corporate Affairs, Mathias Nilsen Reierth, meeting with partners, customers, and industry colleagues from across the radiopharmaceutical ecosystem. Thank you to everyone we met for the valuable discussions, and not least the many enjoyable conversations throughout the week. Society of Nuclear Medicine and Molecular Imaging (SNMMI) https://www.linkedin.com/posts/society-of-nuclear-medicine-and-molecular-imaging_the-meeting-has-wound-down-but-the-energy-activity-7467737453555159040-pape?utm_source=share&utm_medium=member_ios&rcm=ACoAACnoG9EBkv5mlEYH6hUCttebCtIGaxofGIg #SNMMI2026 #Pb212 #TargetedAlphaTherapy #Radiopharmaceuticals #ThorMedical
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
98 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·45 min sittenI have been in the stock for some years, and I felt the same way as many of you. But every year I have looked, it has risen enormously. Get rid of stress and put the stock on the shelf for some months and come back 😊 I do that at least haha - not advice
- ·5 t sittenShould we all just smile and be content no matter what happens? When a company that seemingly has everything in order, is ready for production, and has a market that actually demands the product, falls nearly 11 % in four trading days – then I become skeptical. I still have faith, and I will continue to have it, but these are unhealthy fluctuations when only positive news is available. There is, of course, a lot of speculation and forces at play, but for 1/10 of the value of an entire company to disappear in under a week without a single piece of negative news, that's not good. So we'll see what happens going forward. I'm crossing my fingers that it turns around and stabilizes, but I must admit that I'm starting to wonder if the price target of 3,5 is realistic after all. Anyway – fingers crossed for a more stable journey ahead, with the arrow pointing upwards. Fingers crossed.·3 t sittenWhat is happening now is completely normal. 3,5 I see as almost impossible. I guess the stock will accumulate well around 4 kr.
- ·5 t sittenThe stock is therefore experiencing significant volatility because investors are weighing DNB's fear of high short-term costs against Arctic's optimism regarding the accelerating global demand.
- ·7 t sittenIt looks like it is being systematically worked down. Smart move.·5 t sitten · MuokattuAnyway, this level is not a big concern, it has been here several times, most recently in May. It was also significantly lower than this early in winter. An excellent buying opportunity for those who might want more shares. I bet we are a good way up when certificate of commission is signed, perhaps already before we take summer vacation. By the way, it's been a sad week in the entire stock world, a lot of red around the globe.
- 10 t sitten10 t sittenSNMMI 2026, one of the world's leading events for nuclear medicine - it's a wrap. A clear takeaway from this year's meeting in Los Angeles was the growing interest in lead-212 and the continued momentum behind targeted alpha therapies. It was a productive week for Thor Medical's CEO, Jasper C. Kurth, and Head of Communications & Corporate Affairs, Mathias Nilsen Reierth, meeting with partners, customers, and industry colleagues from across the radiopharmaceutical ecosystem. Thank you to everyone we met for the valuable discussions, and not least the many enjoyable conversations throughout the week. Society of Nuclear Medicine and Molecular Imaging (SNMMI) https://www.linkedin.com/posts/society-of-nuclear-medicine-and-molecular-imaging_the-meeting-has-wound-down-but-the-energy-activity-7467737453555159040-pape?utm_source=share&utm_medium=member_ios&rcm=ACoAACnoG9EBkv5mlEYH6hUCttebCtIGaxofGIg #SNMMI2026 #Pb212 #TargetedAlphaTherapy #Radiopharmaceuticals #ThorMedical
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 3 332 | - | - | ||
| 17 034 | - | - | ||
| 3 127 | - | - | ||
| 2 834 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
2025 H2 -tulosraportti
98 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·45 min sittenI have been in the stock for some years, and I felt the same way as many of you. But every year I have looked, it has risen enormously. Get rid of stress and put the stock on the shelf for some months and come back 😊 I do that at least haha - not advice
- ·5 t sittenShould we all just smile and be content no matter what happens? When a company that seemingly has everything in order, is ready for production, and has a market that actually demands the product, falls nearly 11 % in four trading days – then I become skeptical. I still have faith, and I will continue to have it, but these are unhealthy fluctuations when only positive news is available. There is, of course, a lot of speculation and forces at play, but for 1/10 of the value of an entire company to disappear in under a week without a single piece of negative news, that's not good. So we'll see what happens going forward. I'm crossing my fingers that it turns around and stabilizes, but I must admit that I'm starting to wonder if the price target of 3,5 is realistic after all. Anyway – fingers crossed for a more stable journey ahead, with the arrow pointing upwards. Fingers crossed.·3 t sittenWhat is happening now is completely normal. 3,5 I see as almost impossible. I guess the stock will accumulate well around 4 kr.
- ·5 t sittenThe stock is therefore experiencing significant volatility because investors are weighing DNB's fear of high short-term costs against Arctic's optimism regarding the accelerating global demand.
- ·7 t sittenIt looks like it is being systematically worked down. Smart move.·5 t sitten · MuokattuAnyway, this level is not a big concern, it has been here several times, most recently in May. It was also significantly lower than this early in winter. An excellent buying opportunity for those who might want more shares. I bet we are a good way up when certificate of commission is signed, perhaps already before we take summer vacation. By the way, it's been a sad week in the entire stock world, a lot of red around the globe.
- 10 t sitten10 t sittenSNMMI 2026, one of the world's leading events for nuclear medicine - it's a wrap. A clear takeaway from this year's meeting in Los Angeles was the growing interest in lead-212 and the continued momentum behind targeted alpha therapies. It was a productive week for Thor Medical's CEO, Jasper C. Kurth, and Head of Communications & Corporate Affairs, Mathias Nilsen Reierth, meeting with partners, customers, and industry colleagues from across the radiopharmaceutical ecosystem. Thank you to everyone we met for the valuable discussions, and not least the many enjoyable conversations throughout the week. Society of Nuclear Medicine and Molecular Imaging (SNMMI) https://www.linkedin.com/posts/society-of-nuclear-medicine-and-molecular-imaging_the-meeting-has-wound-down-but-the-energy-activity-7467737453555159040-pape?utm_source=share&utm_medium=member_ios&rcm=ACoAACnoG9EBkv5mlEYH6hUCttebCtIGaxofGIg #SNMMI2026 #Pb212 #TargetedAlphaTherapy #Radiopharmaceuticals #ThorMedical
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 3 332 | - | - | ||
| 17 034 | - | - | ||
| 3 127 | - | - | ||
| 2 834 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt